Estimated glomerular filtration rate, or eGFR, is the single most important number for gauging how well your kidneys filter waste from your blood. It represents the volume of plasma your kidneys’ filtering units process each minute, and it is reported in milliliters per minute per 1.73 square meters of body surface area (mL/min/1.73 m²).1PubMed. Physiology, Glomerular Filtration Rate A healthy young adult typically has an eGFR above 90, while values below 60 sustained over three months generally signal chronic kidney disease. But a single number on a lab printout can be misleading without understanding what feeds into it, what throws it off, and how fast it is changing.
What the Standard eGFR Ranges Mean
Most labs report eGFR alongside a staging system based on guidelines from the international kidney disease organization KDIGO. The stages break down roughly like this:
- 90 or above: Normal or high kidney function. If there are no other signs of kidney damage (such as protein in urine), this is considered healthy.
- 60 to 89: Mildly decreased function. Many people in this range have no symptoms and may never develop kidney problems, especially if they are older, since eGFR naturally drops with age.
- 45 to 59 (stage 3a): Mild to moderate decrease. This is often where doctors start paying closer attention, checking for protein in urine and adjusting medications that are cleared by the kidneys.
- 30 to 44 (stage 3b): Moderate to severe decrease. Complications like anemia, bone-mineral imbalances, and high blood pressure become more common here.
- 15 to 29 (stage 4): Severely decreased function. Planning for dialysis or transplant evaluation typically begins.
- Below 15 (stage 5): Kidney failure. The kidneys can no longer sustain life without dialysis or a transplant, though the exact timing depends on symptoms rather than the number alone.
These cutoffs are useful as a shorthand, but they were designed for populations, not for reading any one person’s result in isolation. A 25-year-old with an eGFR of 70 is in a very different situation from a 78-year-old with the same number, because the expected trajectory and the underlying cause are different.
How eGFR Is Calculated
Your lab does not measure GFR directly. Instead, it plugs your blood creatinine level, along with your age and sex, into a formula that estimates what your true filtration rate probably is. The most widely used formula today is the 2021 CKD-EPI creatinine equation, which replaced older versions that included a race coefficient. Removing the race variable was a deliberate shift: research showed that using race as a factor systematically reclassified a meaningful share of Black patients into lower-risk categories, potentially delaying referrals and treatment.2PubMed Central. Impact of Removing Race Variable on CKD Classification Using the Creatinine-Based 2021 CKD-EPI Equation
Creatinine is a waste product from muscle metabolism, so anything that changes your muscle mass or creatinine production can skew the estimate. A second blood marker called cystatin C offers an alternative. It is produced by virtually all cells in the body, not just muscle, so it is less sensitive to how muscular you are. An equation that combines both creatinine and cystatin C tends to be more accurate than either marker alone, especially in the 45-to-59 range where staging decisions matter most and in elderly or non-white populations where creatinine alone is less reliable.3PubMed Central. Should Cystatin C eGFR Become Routine Clinical Practice? Many nephrologists now order cystatin C as a confirmatory test when the creatinine-based eGFR looks borderline or when something about the patient’s body composition makes creatinine unreliable.
Why Your eGFR Might Be Wrong
The most common reason eGFR misleads people is body composition. Creatinine comes from muscle, so a very muscular person produces more of it and can end up with an eGFR that looks artificially low, while someone who has lost significant muscle mass from illness or aging can get a falsely reassuring high number. Research using full-body scans to measure lean mass found that every additional 10 kilograms of muscle was associated with an eGFR underestimate of roughly 6 mL/min, a clinically meaningful error. Fat mass, by contrast, had no effect.4EClinicalMedicine. How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy
Cystatin C has its own blind spots. Obesity can raise cystatin C levels independent of kidney function. Studies have found that the odds of elevated cystatin C roughly double in people with class I obesity compared to those at a normal weight, even after adjusting for other health factors.5PubMed Central. Overweight and obesity and elevated serum cystatin C levels in US adults This means a cystatin C-based eGFR can underestimate kidney function in someone who is significantly overweight. Neither marker is perfect, which is why combining them in a single equation helps cancel out individual errors.
Other common factors that temporarily shift creatinine without reflecting real kidney damage include high-protein meals eaten shortly before a blood draw, intense exercise within the prior 24 hours, and certain medications like trimethoprim that block creatinine secretion into the urine. If a single eGFR result looks unexpectedly low, it is worth checking whether any of these transient influences were in play before assuming your kidneys have declined.
How Age Affects the Numbers
Kidney filtration begins to decline for most people somewhere between the ages of 30 and 40, with the rate of loss possibly accelerating after 50 or 60.6PubMed Central. Ageing and the glomerular filtration rate: truths and consequences A large German population study estimated the average loss at about 1 mL/min per year starting in the third decade of life, meaning a person in their seventies may have lost over 40 mL/min compared to their peak.7Scientific Reports. Distribution of estimated glomerular filtration rate and determinants of its age dependent loss in a German population-based study A systematic review of studies in healthy adults without hypertension reported more conservative mean annual declines in the range of about 0.4 to 1.1 mL/min per year.8BMJ Open. Rate of decline in kidney function with age: a systematic review
This natural decline is why an eGFR of 65 in a healthy 80-year-old does not carry the same alarm as the same number in a 35-year-old. A younger person with a moderately reduced eGFR has decades of potential further decline ahead, making it essential to identify the cause early. In an older adult, the same value may represent nothing more than normal aging, especially if the number has been stable over time and there is no protein in the urine.
Why the Trend Matters More Than a Single Number
A snapshot eGFR tells you where your kidney function is right now. The slope of eGFR over time tells you where it is heading, which is often more useful. In patients with type 2 diabetes, for example, a one-year eGFR decline of more than about 7.5% was highly predictive of eventual kidney failure, with sensitivity above 98%.9PubMed Central. One-year eGFR decline rate is a good predictor of prognosis of renal failure in patients with type 2 diabetes That finding illustrates why nephrologists track eGFR over several visits rather than reacting to one result.
Diabetes itself accelerates the rate of decline. In one study of patients with chronic kidney disease, those with diabetes lost eGFR at roughly twice the rate of those without, even after adjusting for age, sex, race, and blood pressure medications.10The American Journal of the Medical Sciences. Rate of eGFR decline in patients with and without diabetes and chronic kidney disease This is one reason that tight blood sugar management and blood pressure control remain the cornerstones of slowing kidney disease progression.
Combining eGFR with Urine Albumin for a Clearer Picture
Your eGFR reflects filtration capacity, but it does not tell you whether the kidneys are leaking protein they should be keeping. A urine albumin-to-creatinine ratio (uACR) captures that dimension. Current guidelines recommend looking at eGFR and uACR together, because the combination predicts outcomes better than either one alone. In a large cohort study of adults aged 75 and older, pairing the two measurements into a risk matrix revealed a clear, stepwise gradient of mortality risk: the worst outcomes clustered among people with both a low eGFR and high albumin excretion.11PubMed Central. Implementation of KDIGO CKD Screening and Its Prognostic Implications in Community-Dwelling Adults Aged 75 Years or Older You can have a modestly reduced eGFR with no albumin leakage and be at relatively low risk, or you can have a normal eGFR with significant albumin in the urine and face a higher chance of progression. The combination is what tells the real story.
How eGFR Affects Medication Dosing
One of the most practical consequences of a reduced eGFR is that many common medications need dose adjustments to avoid toxicity. When kidneys filter more slowly, drugs that are cleared through the urine accumulate in the blood. Among the medications most frequently requiring adjustment when eGFR drops below 60 are famotidine (a heartburn drug), metformin (the most common diabetes medication), gabapentinoids (used for nerve pain), and anticoagulants (blood thinners).12Kidney360. Implementation of an Electronic Drug-Dosing Decision Support Kidney Tool for Pharmacists
There is a technical wrinkle here that matters for patients with unusual body size. Standard eGFR values are indexed to a body surface area of 1.73 m², which was the average body surface area of young adults when the convention was first set decades ago. For drug dosing, what you actually need is the absolute volume your kidneys filter per minute, not the volume adjusted for a theoretical body size. Research in kidney transplant recipients found that using non-indexed eGFR equations (reported simply in mL/min rather than mL/min/1.73 m²) resulted in substantially fewer dosing errors, especially in patients with obesity, where the indexed version led to frequent underdosing.13PubMed. Comparison of eGFR Equations to Guide Dosing of Medications for Kidney Transplant Recipients If you are significantly larger or smaller than average and take kidney-cleared medications, this distinction is worth raising with your pharmacist.
When a Drop in eGFR Is Actually a Good Sign
A class of diabetes and heart failure medications called SGLT2 inhibitors (drugs like empagliflozin and dapagliflozin) reliably cause a dip in eGFR during the first weeks of use. This initial drop can look alarming on a lab report, but it reflects a change in kidney blood flow rather than actual kidney damage. Research using directly measured GFR found that the early decline was associated with improved flexibility of large blood vessels, indicating the drug’s intended effect on the vascular system.14PubMed Central. Is GFR decline induced by SGLT2 inhibitor of clinical importance? Over the longer term, SGLT2 inhibitors actually slow kidney function loss compared to placebo. Patients who see their eGFR drop by a few points after starting one of these medications should discuss the result with their prescriber before stopping the drug.
Acute kidney injury (AKI), by contrast, is a sudden drop in eGFR that does signal real damage. Each episode of AKI was associated with an immediate reduction in kidney function of about 1 to 2 mL/min even after adjusting for other risk factors, though the long-term rate of further decline did not clearly accelerate afterward in one large study.15Kidney International. Association of acute kidney injury and subsequent kidney function trajectory: the ASSESS-AKI study The practical implication is that recovering from AKI does not necessarily mean your kidneys will deteriorate faster going forward, but you do not get back the function you lost during the episode.
eGFR and the Decision to Start Dialysis
People with advanced kidney disease often fixate on the eGFR number that will “trigger” dialysis, but there is no fixed threshold. A landmark randomized trial called IDEAL compared starting dialysis at a higher eGFR (10 to 14) versus a lower eGFR (5 to 7) and found no mortality benefit to earlier initiation.16PubMed. Dialysis for Chronic Kidney Failure: A Review Current guidelines emphasize shared decision-making based on symptoms like persistent nausea, fatigue, shortness of breath, and swelling, along with lab markers of metabolic trouble. In patients without symptoms, dialysis can often be safely delayed until eGFR falls to at least 5 to 7.17PubMed. When to initiate dialysis for end-stage kidney disease: evidence and challenges
One reason the eGFR number itself is a poor trigger is that creatinine-based formulas become less accurate at the very low filtration rates seen in advanced kidney disease. At that stage, a person’s residual kidney function, symptoms, nutritional status, and ability to manage fluid balance matter far more than a number that may be off by several points.
Diet and Its Effect on eGFR Decline
Restricting dietary protein is one of the oldest recommended interventions for slowing kidney disease progression, but the evidence is more complicated than many patients realize. A large Cochrane review of studies in non-diabetic adults with CKD found that low-protein diets made little to no difference in the number of people who progressed to kidney failure, and the effect on GFR change was uncertain.18PubMed Central. Low protein diets for non‐diabetic adults with chronic kidney disease That finding surprised many people in the field, since the logic behind protein restriction (less protein means less filtration workload) seems straightforward.
A more promising approach may be supplementing a low-protein diet with ketoanalogues, which are modified amino acids that provide essential nutrition without the nitrogen waste burden. In a cohort of pre-dialysis CKD patients followed for a median of about 33 months, those on a low-protein diet plus ketoanalogues had a significantly slower rate of eGFR decline, roughly 4.5 mL/min per year compared to 7.7 mL/min per year on a low-protein diet alone.19PubMed Central. The role of a low protein diet supplemented with ketoanalogues on kidney progression in pre-dialysis chronic kidney disease patients Ketoanalogue supplementation is more common in parts of Europe and Asia than in North America, where availability and cost remain barriers. Any significant dietary change aimed at protecting kidney function should be managed with a dietitian, since excessive protein restriction without supplementation carries its own risks of malnutrition.
eGFR in Children
The adult CKD-EPI equations do not work in children. Kids have lower muscle mass relative to body size, and their creatinine levels change rapidly with growth, so pediatric formulas use height as a key input. The most widely used is the modified Schwartz formula, which was developed specifically for children and adolescents.20PubMed. Modified Schwartz formula and (99m)Tc-DTPA plasma clearance methods to calculate glomerular filtration rate in critically ill children Newer pediatric equations also incorporate cystatin C and other markers.21PubMed Central. Glomerular Filtration Rate Estimation Formulas for Pediatric and Neonatal Use Normal eGFR values in children increase from birth through early childhood and approach adult levels by roughly age two, so the same number means very different things at different ages. If your child’s lab report shows an eGFR, it should have been calculated with a pediatric formula; if the lab used an adult equation, the result is unreliable.
Emerging Biomarkers Beyond Creatinine and Cystatin C
Researchers are investigating additional blood markers that could improve eGFR accuracy, particularly for populations where creatinine and cystatin C are both unreliable. Two of the most studied are beta-2-microglobulin (B2M) and beta-trace protein (BTP). Both are small proteins filtered by the kidneys, and both appear to be less influenced by race and body composition than creatinine.22PubMed Central. A New Panel-Estimated GFR, Including β(2)-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population When used individually, neither B2M nor BTP is as accurate as creatinine or cystatin C for estimating GFR. But when combined with creatinine into a three- or four-marker panel, they match or exceed the accuracy of the current two-marker approach.23PubMed Central. GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD
In cancer patients, where both creatinine and cystatin C can be thrown off by the disease itself or by chemotherapy, B2M and BTP may serve as useful confirmatory tests. A prospective study in adults with solid tumors found that adding these markers to a panel with creatinine improved accuracy compared to creatinine-cystatin C equations alone.24PubMed. Glomerular Filtration Rate Estimation Using β(2)-Microglobulin and β-Trace Protein in Adults With Solid Tumors These markers are not yet part of standard lab panels, but they represent a direction the field is moving: toward multi-marker equations that are less dependent on any single assumption about the patient’s body.
Understanding Your Results in Context
Health literacy plays a real role in how well people manage kidney disease. A study examining the relationship between health literacy and eGFR found a small but significant association, with lower literacy linked to lower kidney function, likely mediated through poorer self-management behaviors.25PubMed. Relationship between Health Literacy and Kidney Function If you have looked up what your eGFR means, you are already doing more than many patients. The key points to bring into a conversation with your doctor are straightforward: ask whether your eGFR trend is stable or declining, whether you have albumin in your urine, and whether any of your medications need dose adjustments at your current level of kidney function. Those three questions cover the information that actually changes management decisions at every stage of kidney disease.